Retatrutide, a new dual stimulator of the GLP-1 binding site and glucose-dependent released polypeptide (GIP) receptor , is demonstrating promising data in early clinical trials . Ongoing research https://nowbookmarks.com/story21414892/retatrutide-emerging-investigations-and-potential-therapeutic-applications